Trial Profile
Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 22 Nov 2023
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 16 Nov 2023 Status changed from active, no longer recruiting to discontinued due to global pandemic.
- 03 May 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 03 May 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.